← CareDx, Inc. CDNA
Market Price
$45.31
Market Cap
$2.45B
P/E Ratio
N/A
Revenue (FY 2025)
↑13.8% YoY
$379.81M
3-Yr CAGR: 5.7%
Net Income
↓-140.6% YoY
-$21.35M
Net Margin: -5.6%
Free Cash Flow
↑12.3% YoY
$35.44M
FCF Yield: 1.45%
EPS (Diluted)
↓-143.0% YoY
$-0.40
Basic: $-0.40
Return on Equity
Efficiency
-7.0%
ROA: -201.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CDNA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $40.6M | — | $30.4M | $-39.5M | — | $-2.39 | — | $-16.5M | $-17.1M | — |
| FY 2017 | $48.3M | +18.9% | $39.3M | $-55.5M | -40.5% | $-2.38 | +0.4% | $-14.3M | $-14.5M | +15.1% |
| FY 2018 | $76.6M | +58.4% | $6.4M | $-46.8M | +15.7% | $-1.31 | +45.0% | $-4.0M | $-6.0M | +58.3% |
| FY 2019 | $127.1M | +66.0% | $81.6M | $-22.0M | +53.0% | $-0.52 | +60.3% | $-2.8M | — | — |
| FY 2020 | $192.2M | +51.3% | $26.3M | $-18.7M | +14.8% | $-0.40 | +23.1% | $33.4M | — | — |
| FY 2021 | $296.4M | +54.2% | $45.2M | $-30.7M | -63.8% | $-0.59 | -47.5% | $-19.3M | — | — |
| FY 2022 | $321.8M | +8.6% | $23.2M | $-76.6M | -149.9% | $-1.44 | -144.1% | $-25.2M | $-49.6M | — |
| FY 2023 | $280.3M | -12.9% | $205.9M | $-190.3M | -148.4% | $-3.54 | -145.8% | $-18.4M | $-27.6M | +44.3% |
| FY 2024 | $333.8M | +19.1% | $164.5M | $52.5M | +127.6% | $0.93 | +126.3% | $38.0M | $31.6M | +214.2% |
| FY 2025 | $379.8M | +13.8% | $76.8M | $-21.4M | -140.6% | $-0.40 | -143.0% | $42.0M | $35.4M | +12.3% |
Valuation
Market Price
$45.31
Market Cap
$2.45B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
7.72
FCF Yield
1.45%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
20.22%
Operating Margin
-8.10%
Net Margin
-5.62%
Return on Equity (ROE)
-7.05%
Return on Assets (ROA)
-201.62%
Asset Turnover
35.86x
Revenue 3-Yr CAGR
5.68%
Financial Health & Liquidity
Current Ratio
0.12
Cash Ratio
0.73
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$65.43M
Total Debt
N/A
Book Value / Share
$5.87
Cash Flow Efficiency
Operating Cash Flow
$42.03M
Capital Expenditures (CapEx)
$6.59M
Free Cash Flow
$35.44M
OCF / Revenue
11.07%
FCF / Revenue
9.33%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.40
EPS (Basic)
$-0.40
Dividends / Share
N/A
Book Value / Share
$5.87
EPS YoY Growth
-143.01%
Balance Sheet (FY 2025)
Total Assets
$10.59M
Total Liabilities
$89.85M
Stockholders' Equity
$303.10M
Current Assets
$10.59M
Current Liabilities
$89.85M